Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Chemotherapy

The role of ifosfamide and etoposide in Ewing sarcoma

Nature Reviews Clinical Oncology volume 6, pages 251–253 (2009)Cite this article

The EICESS-92 trial compared the efficacy of cyclophosphamide and ifosfamide in patients with Ewing sarcoma. Subgroup analysis suggested that patients with large, localized tumors benefited from the addition of etoposide, whereas patients with metastases did not.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Paulussen, M. et al. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment—cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J. Clin. Oncol. 26, 4385–4393 (2008).

    Article  CAS  Google Scholar 

  2. Magrath, I. et al. A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people. Cancer Chemother. Pharmacol. 18, S25–S28 (1986).

    Article  Google Scholar 

  3. Miser, J. S. et al. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J. Clin. Oncol. 5, 1191–1198 (1987).

    Article  CAS  Google Scholar 

  4. Oberlin, O. et al. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology. J. Clin. Oncol. 10, 1407–1412 (1992).

    Article  CAS  Google Scholar 

  5. Craft, A. et al. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. J. Clin. Oncol. 16, 3628–3633 (1998).

    Article  CAS  Google Scholar 

  6. Paulussen, M. et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J. Clin. Oncol. 19, 1818–1829 (2001).

    Article  CAS  Google Scholar 

  7. Grier, H. E. et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N. Engl. J. Med. 348, 694–701 (2003).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California San Francisco (UCSF) School of Medicine, San Francisco, CA, USA

    Steven G. DuBois

  2. Harvard Medical School, Boston, MA, USA

    Holcombe E. Grier

Authors
  1. Steven G. DuBois
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Holcombe E. Grier
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Holcombe E. Grier.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

DuBois, S., Grier, H. The role of ifosfamide and etoposide in Ewing sarcoma. Nat Rev Clin Oncol 6, 251–253 (2009). https://doi.org/10.1038/nrclinonc.2009.25

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2009.25

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing